Welcome to the Zero Jargon Health blog. When reviewing national health data, headline figures often tell only half the story. Recently, there has been significant discussion regarding how HIV is transmitted in the UK, particularly concerning the breakdown by sexuality. With an estimated 111,800 people living with HIV across the UK, understanding the current demographics of transmission is essential for shaping public health policy, championing equality, and eradicating stigma.
The Current Population vs. New Diagnoses
First, it is important to distinguish between the total population currently living with HIV and those newly diagnosed. Among the total population accessing treatment today, the split is broadly even: approximately 50% acquired the virus through heterosexual contact, and roughly 50% through male same-sex contact (gay, bisexual, and other men who have sex with men, or GBMSM).
However, looking at the most recent provisional data for new diagnoses in England, a marked shift has occurred:
Heterosexual Contact: This group now accounts for around 50% of all new diagnoses, with people of Black African ethnicity remaining disproportionately affected due to intersecting systemic barriers.
Gay and Bisexual Men: This demographic accounts for approximately 29% of new diagnoses.
This shift represents a monumental success in targeted public health programmes. The widespread adoption of preventative medications, alongside rapid access to treatment, has driven new diagnoses among gay and bisexual men to record lows.
Decoding the 'Unreported' Data
If heterosexuals account for 50% of new diagnoses and GBMSM for 29%, who makes up the remaining 21%?
The reality is that this remaining percentage is largely composed of 'undetermined' or 'unreported' cases. When a person first tests positive—especially via an emergency department opt-out scheme or a home testing kit—the immediate clinical priority is their health and getting them onto a treatment pathway. Recording a detailed sexual history takes a back seat. Consequently, a large portion of the most recent data is initially filed as undetermined.
As patient files are updated over time, these unknown cases are almost always reclassified. When public health bodies look strictly at new diagnoses where the route of transmission is confirmed, over 95% are attributed to sexual contact. Filtered for known exposure routes, the split typically settles at around 60–65% via heterosexual contact and 30–35% via GBMSM.
Living with HIV: Life Expectancy and ART
Decades ago, an HIV diagnosis was widely feared as a terminal illness. Today, thanks to phenomenal advancements in Antiretroviral Therapy (ART), the medical reality is entirely different. HIV is now classified as a manageable, long-term health condition.
If an individual is diagnosed promptly and takes their ART daily as prescribed, their life expectancy is comparable to that of someone who does not have HIV. The medication effectively protects the immune system from damage, allowing people living with the virus to lead long, healthy, and fulfilling lives.
The critical factor for longevity is early detection. This is why routine testing and the expansion of emergency department opt-out schemes are so vital. The sooner an individual knows their status, the sooner they can begin treatment, ensuring their immune system remains strong so they can continue living their life without compromise.
Prevention Powerhouses: PrEP and PEP
Highly effective medications are also available on the NHS for HIV-negative individuals to prevent them from acquiring the virus.
PrEP (Pre-Exposure Prophylaxis) is a preventative medication taken before potential exposure. It works by ensuring there is already enough of the drug in the body to block the virus from taking hold. When taken correctly as prescribed, PrEP is almost 100% effective at preventing HIV.
PEP (Post-Exposure Prophylaxis) serves as an emergency measure. If an individual believes they have been exposed to the virus, they can take a 28-day course of PEP to stop an infection from establishing. To be effective, PEP must be started within 72 hours of exposure.
Condom Effectiveness: The Reliable Barrier
While modern medication has revolutionised HIV prevention, condoms remain a cornerstone of comprehensive sexual health. When used correctly and consistently, condoms are highly effective at preventing the transmission of HIV. In laboratory testing, intact condoms are completely impermeable to the virus. In real-world application, their effectiveness is slightly reduced only by human error, such as incorrect application, slipping, or breaking.
Crucially, unlike PrEP or PEP, condoms provide a vital physical barrier that protects against a wide spectrum of other sexually transmitted infections (STIs) and unplanned pregnancies. To maximise their effectiveness:
Use a new condom for every sexual act.
Ensure the condom is put on before any sexual contact occurs.
Only use water-based or silicone-based lubricants. Oil-based lubricants (such as petroleum jelly or body lotions) weaken latex condoms and significantly increase the likelihood of them breaking.
Condoms are a highly accessible tool that empowers individuals of all genders and sexualities to take shared responsibility for their sexual health.
How Medication Prevents Transmission: U=U
Beyond PrEP, PEP, and condoms, how does HIV medication stop the virus from being passed on by someone already living with it? It comes down to a globally recognised medical consensus known as Undetectable = Untransmittable, or U=U.
When a person living with HIV takes ART daily as prescribed, the medication actively stops the virus from replicating in their body. Over a period of three to six months, the amount of the virus in their blood drops to such low levels that standard laboratory tests can no longer detect it.
Once a person’s viral load has remained undetectable, there is zero risk of them passing the virus on to a sexual partner. The protection provided by ART is absolute: it applies to all forms of sex and remains effective even if other sexually transmitted infections are present.
Key insight: Treatment as prevention has revolutionised HIV care. By ensuring people living with HIV have equitable access to daily medication, it not only protects their long-term health but actively halts the chain of transmission.
The Rarer Routes of Transmission
Once sexual transmission is accounted for, the remaining verifiable routes make up a very small fraction of cases in the UK:
Injecting Drug Use (1–2%): Sustained harm reduction strategies and needle exchange programmes have kept these figures consistently low.
Vertical Transmission (around 1%): Thanks to rigorous prenatal screening, mother-to-child transmission during pregnancy or childbirth is exceedingly rare in the UK healthcare system.
Blood or Tissue Products (less than 1%): Due to strict screening of the UK blood supply, infections via this route are almost non-existent domestically.
Political Commitment to Ending Transmission
The current Government has reiterated its commitment to ending new HIV transmissions by 2030. The expansion of opt-out testing in emergency departments has been highly effective at identifying undiagnosed individuals across diverse communities.
Wes Streeting MP, Secretary of State for Health and Social Care, has been vocal about the importance of expanding these programmes to ensure no community is left behind. Emphasising the life-saving impact of diagnostic interventions, he noted that opt-out testing has identified over 1,300 people living with HIV who were unaware of their status.
By focusing on community access, dismantling systemic inequalities, and educating the public on realities like modern life expectancy, U=U, PrEP, and condom efficacy, achieving the goal of zero new transmissions is well within reach.
References
Department of Health and Social Care (2025) HIV Action Plan for England, 2025 to 2030. Available at: https://www.gov.uk/government/publications/hiv-action-plan-for-england-2025-to-2030/hiv-action-plan-for-england-2025-to-2030
i-Base (2025) U=U: Undetectable = Untransmittable. Available at: https://i-base.info/u-equals-u/
NHS (2024) Treatment: HIV and AIDS. Available at: https://www.nhs.uk/conditions/hiv-and-aids/treatment/
NHS inform (2026) Condoms. Available at: https://www.nhsinform.scot/healthy-living/contraception/condoms/
Terrence Higgins Trust (2026) PEP (post-exposure prophylaxis for HIV). Available at: https://tht.org.uk/hiv/protection/pep-post-exposure-prophylaxis-hiv
Terrence Higgins Trust (2026) PrEP (pre-exposure prophylaxis). Available at: https://tht.org.uk/hiv/protection/prep-pre-exposure-prophylaxis
Terrence Higgins Trust (2025) “Our HIV response is not just a priority for me in this job, it is a source of inspiration” says Health Secretary Wes Streeting. Available at: https://tht.org.uk/about-us/our-campaigns/our-hiv-response-not-just-priority-me-job-it-source-inspiration-says-health
UK Health Security Agency (2025) HIV testing, PrEP, new HIV diagnoses and care outcomes for people accessing HIV services: 2025 report. Available at: https://www.gov.uk/government/statistics/hiv-annual-data/hiv-testing-prep-new-hiv-diagnoses-and-care-outcomes-for-people-accessing-hiv-services-2025-report
World Health Organisation (2025) Condoms. Available at: https://www.who.int/news-room/fact-sheets/detail/condoms
IMPORTANT MEDICAL DISCLAIMER
The content provided in this blog post is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Always consult with a qualified healthcare professional or your GP before starting any new supplement regimen, particularly if you manage pre-existing conditions or take prescription medication.
No comments:
Post a Comment